SciELO - Scientific Electronic Library Online

 
vol.148 número1Endoscopía luego de cirugía bariátrica: Lo que debe saber el endoscopistaArtículos de Revisión índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

RIOS, Juvenal A. et al. The cardiovascular impact of cancer control therapy. Rev. méd. Chile [online]. 2020, vol.148, n.1, pp.93-102. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872020000100093.

Cardiovascular diseases and cancer account for 27 and 25% of mortality in Chile, respectively. In the last decades, survival of people with cancer has improved due to preventive programs, early detection strategies, advances in technology and development of new antineoplastic therapies. Consequently, a progressive number of cancer-surviving patients have been generated, who may develop cardiovascular diseases, secondary to the same cancer therapy. Cardio-Oncology has emerged as the necessary link between both specialties to promote the prevention and early detection of cardiac complications, in patients undergoing oncological therapies. The aim is to curb cardiovascular complications. Also, to acquire knowledge about the mechanisms and effects of drugs that lead to heart damage aiming to develop efficient cardioprotective therapies. In this article we review and propose a didactic organization and classification of the main cardiovascular effects of cancer control therapy. We recognize that there is still a knowledge gap in basic sciences about the mechanisms that underlie these alterations.

Palabras clave : Anthracyclines; Cardiotoxicity; Drug Therapy; Neoplasms.

        · texto en Español     · Español ( pdf )